文献速递乳腺技术与安全US

超声特征鉴别COVID-19疫苗诱导的良性腺病与乳腺癌相关恶性腺病

Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy.
PubMed 文献 · Acad Radiol · 2022-02-21

该单机构回顾性研究比较了77例mRNA COVID-19疫苗后良性反应性腺病患者与76例活检证实的乳腺癌恶性腺病患者,发现皮质厚度和形态可预测恶性,皮质厚度≥5.4 mm较≥3.0 mm具有更高特异度和准确率。

要点

  • 良性淋巴结平均皮质厚度5.1 mm,恶性为8.9 mm,差异有统计学意义(p < 0.001)。
  • 皮质厚度≥5.4 mm时敏感度74%、特异度69%(AUC=0.77),优于≥3.0 mm的100%和21%(AUC=0.60)。
  • 与弥漫均匀皮质增厚相比,分叶状皮质增厚OR=7.5,局灶性皮质分叶OR=123.0(p < 0.001)。

核心结论

  • 皮质厚度和形态可预测恶性,皮质厚度≥5.4 mm较≥3.0 mm对检出恶性腺病具有更高特异度和准确率。

研究设计与样本

  • IRB批准的单机构回顾性研究,纳入77例mRNA COVID-19疫苗后继发良性腺病连续患者与76例活检证实的乳腺癌恶性腺病患者,采用单变量和多变量逻辑回归比较人口学与淋巴结特征,并以约登指数最大值确定皮质厚度截断值行ROC分析。

关键影像表现/征象

  • 良性淋巴结平均皮质厚度5.1 mm ± 2.8 mm,恶性淋巴结8.9 mm ± 4.5 mm(p < 0.001)。
  • 皮质厚度与淋巴结形态类型相关(r2 = 0.57)。
  • 与仅弥漫均匀皮质增厚的腋窝淋巴结相比,广泛分叶状皮质增厚的OR为7.5,局灶性皮质分叶的OR为123.0(p < 0.001)。

诊断标准与关键数值

  • 皮质厚度≥3.0 mm预测恶性:敏感度100%,特异度21%,AUC=0.60(95%CI:0.52-0.68)。
  • 皮质厚度≥5.4 mm预测恶性:敏感度74%,特异度69%,AUC=0.77(95%CI:0.70-0.84)。

临床应用与阅片要点

  • 评估腋窝淋巴结时,除皮质厚度外还应关注皮质增厚形态是弥漫均匀、广泛分叶状还是局灶性分叶。
  • 皮质厚度≥5.4 mm较≥3.0 mm对恶性腺病的特异度更高,但敏感度降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVE: To identify nodal features used to distinguish coronavirus disease 2019 (COVID-19) vaccine-Induced benign reactive adenopathy from malignant adenopathy.

MATERIALS AND METHODS: This IRB-approved, single-institution, retrospective study compared features of 77 consecutive patients with benign adenopathy secondary to a messenger RNA COVID-19 vaccine with 76 patients with biopsy-proven malignant adenopathy from breast cancer. Patient demographics and nodal features were compared between the two groups using univariate and multivariate logistic regression models. A receiver operating characteristic analysis with the maximum value of Youden's index was performed for the cutoff value of cortical thickness for predicting nodal status.

RESULTS: The mean cortical thickness was 5.1 mm ± 2.8 mm among benign nodes and 8.9 mm ± 4.5 mm among malignant nodes (p < 0.001). A cortical thickness ≥3.0 mm had a sensitivity of 100% and a specificity of 21% (area under the curve [AUC] = 0.60, 95% confidence interval [CI]: 0.52-0.68). When the cutoff for cortical thickness was increased to ≥5.4 mm, the sensitivity decreased to 74%, while the specificity increased to 69% (AUC = 0.77, 95% CI: 0.70-0.84).Cortical thickness correlated with nodal morphology type (r2 = 0.57). An axillary node with generalized lobulated cortical thickening had a 7.5 odds ratio and a node with focal cortical lobulation had a 123.0 odds ratio compared to one with diffuse, uniform cortical thickening only (p < 0.001).

CONCLUSION: Cortical thickness and morphology are predictive of malignancy. Cortical thickness cutoff of ≥5.4 mm demonstrates higher specificity and improved accuracy for detecting malignant adenopathy than a cutoff of ≥3.0 mm.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Hl, Gj, Jwt, et al. Ultrasound Features to Differentiate COVID-19 Vaccine-Induced Benign Adenopathy from Breast Cancer Related Malignant Adenopathy. Acad Radiol. 2022. PMID: 35296413. doi:10.1016/j.acra.2022.02.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。